Chiron Real Estate Inc. (XRN) Earnings
Chiron Real Estate Inc. is expected to report next earnings on August 4, 2026 (in NaN days), with a consensus EPS estimate of $-0.16. XRN has beaten EPS estimates in 2 of its last 2 reported quarters (average surprise +10004.2% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 7, 2026 | $0.01 | $0.97 | +19300.0% | $38M | -0.5% |
| Feb 25, 2026 | $0.12 | $0.97 | +708.3% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q1 FY2026 · May 7, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
Mark discussed Maywin Capital Partners $100 million strategic investment, with Maywin expected to join the board. On a fully diluted as converted basis, over 20% of ownership is on the board. Chiron has approximately $300 million of capital sources to fund ~$425 million of identified investments. Bob provided first quarter operating performance: redefined FFO per share and unit was $0.97, core FFO was $1.11 per share and unit, net debt to adjusted EBITDA was 6.6 times (reduced 0.4 times from last year), same-store cash NOI increased 3.2% year-over-year. Mark mentioned the repositioning work ahead centers on disciplined execution, lease up performance, capital recycling, etc., and thanked Henry Cole and Ron Marston for their service.
Guidance
Withdrawn 2026 earnings guidance to focus on portfolio transition and building long-term shareholder value. Full year expectations for cash and non-cash T&A expenses, as well as capital expenditures included in FAD are in line with previous communications
Segment performance
Not applicable as no specific product segment financial performance details provided
Risks & headwinds
Not explicitly discussed in the provided transcript
Analyst Q&A
Q: Regarding funds for the $425 million announced, are there enough funds?
A: Have a couple hundred million under LOI, including IRFs under LOI and Christus asset in Beaumont, Texas, with other outpatient medical disposals by November 1 to get to leverage neutral proceeds.
Q: Chiron's niche in senior housing investment?
A: Least likely to compete in auctions, will be thoughtful, creative, listen well to help sellers find solutions, seek win-wins.
Q: Plan for additional strategic dispositions?
A: Will trade out outpatient medical for higher quality, better growing cash flows.
Q: Leverage over next year?
A: Ultimate goal is investment grade, depends on opportunity perspective.
Q: Pipeline of investments?
A: Job one is close and integrate current acquisitions, but will also continue to look for interesting opportunities.
Q: Pending acquisitions in D.C. metro area?
A: Happy coincidence, based in DC, but can underwrite anywhere.
Q: Dispositions outside $200 million pending?
A: $125 million are in the future.
Q: When will portfolio get to long-term earnings growth of 6%?
A: Present trough probably next quarter, start to stabilize in 27, 28, with second half of 28 as target